v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-In Capital
Dividends in excess of net income
Accumulated Other Comprehensive Income
Non-Controlling Interest
Balance (in shares) at Dec. 31, 2024   7,000,000 107,248,705        
Balance at Dec. 31, 2024 $ 5,510,661 $ 175,000 $ 10 $ 5,765,582 $ (470,622) $ 40,076 $ 615
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock, net of issuance costs (in shares)     2,665,998        
Issuance of common stock, net of issuance costs 183,091   $ 1 183,090      
Repurchase of common shares (in shares)     (50,038)        
Repurchase of common shares (3,645)     (3,645)      
Issuance of restricted stock under the 2024 Omnibus Incentive Plan (in shares)     153,925        
Stock-based compensation 3,129     3,129      
Series A preferred dividends declared for the period (1,859) (1,859)          
Dividends and distributions declared for the period (82,838)       (82,574)   (264)
Amortization, changes in fair value, and settlement of interest rate swaps (10,767)         (10,732) (35)
Net income 47,148 $ 1,859     45,137   152
Balance (in shares) at Mar. 31, 2025   7,000,000 110,018,590        
Balance at Mar. 31, 2025 5,644,920 $ 175,000 $ 11 5,948,156 (508,059) 29,344 468
Balance (in shares) at Dec. 31, 2024   7,000,000 107,248,705        
Balance at Dec. 31, 2024 5,510,661 $ 175,000 $ 10 5,765,582 (470,622) 40,076 615
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 148,780            
Balance (in shares) at Sep. 30, 2025   7,000,000 114,134,251        
Balance at Sep. 30, 2025 5,873,241 $ 175,000 $ 11 6,247,606 (581,162) 31,528 258
Balance (in shares) at Mar. 31, 2025   7,000,000 110,018,590        
Balance at Mar. 31, 2025 5,644,920 $ 175,000 $ 11 5,948,156 (508,059) 29,344 468
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock, net of issuance costs (in shares)     663,892        
Issuance of common stock, net of issuance costs 41,104     41,104      
Repurchase of common shares (in shares)     (128)        
Repurchase of common shares (9)     (9)      
Forfeiture of restricted stock (in shares)     (16,116)        
Forfeiture of restricted stock (52)     (52)      
Stock-based compensation 3,311     3,311      
Series A preferred dividends declared for the period (1,859) (1,859)          
Dividends and distributions declared for the period (84,919)       (84,652)   (267)
Amortization, changes in fair value, and settlement of interest rate swaps 2,555         2,547 8
Net income 49,353 $ 1,859     47,339   155
Balance (in shares) at Jun. 30, 2025   7,000,000 110,666,238        
Balance at Jun. 30, 2025 5,654,404 $ 175,000 $ 11 5,992,510 (545,372) 31,891 364
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock, net of issuance costs (in shares)     3,468,967        
Issuance of common stock, net of issuance costs 251,851     251,851      
Repurchase of common shares (in shares)     (826)        
Repurchase of common shares (61)     (61)      
Forfeiture of restricted stock (in shares)     (128)        
Stock-based compensation 3,306     3,306      
Series A preferred dividends declared for the period (1,859) (1,859)          
Dividends and distributions declared for the period (86,315)       (86,048)   (267)
Amortization, changes in fair value, and settlement of interest rate swaps (364)         (363) (1)
Net income 52,279 $ 1,859     50,258   162
Balance (in shares) at Sep. 30, 2025   7,000,000 114,134,251        
Balance at Sep. 30, 2025 5,873,241 $ 175,000 $ 11 6,247,606 (581,162) 31,528 258
Balance (in shares) at Dec. 31, 2025   7,000,000 120,028,406        
Balance at Dec. 31, 2025 6,271,153 $ 175,000 $ 12 6,679,142 (618,675) 35,506 168
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Repurchase of common shares (in shares)     (76,363)        
Repurchase of common shares (6,058)     (6,058)      
Issuance of restricted stock under the 2024 Omnibus Incentive Plan (in shares)     151,853        
Forfeiture of restricted stock (in shares)     (441)        
Forfeiture of restricted stock (2)     (2)      
Stock-based compensation 3,536     3,536      
Series A preferred dividends declared for the period (1,859) (1,859)          
Dividends and distributions declared for the period (95,223)       (94,950)   (273)
Amortization, changes in fair value, and settlement of interest rate swaps 5,150         5,135 15
Net income 62,231 $ 1,859     60,192   180
Balance (in shares) at Mar. 31, 2026   7,000,000 120,103,455        
Balance at Mar. 31, 2026 6,238,928 $ 175,000 $ 12 6,676,618 (653,433) 40,641 90
Balance (in shares) at Dec. 31, 2025   7,000,000 120,028,406        
Balance at Dec. 31, 2025 6,271,153 $ 175,000 $ 12 6,679,142 (618,675) 35,506 168
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 185,585            
Balance (in shares) at Sep. 30, 2026   7,000,000 130,101,031        
Balance at Sep. 30, 2026 6,942,612 $ 175,000 $ 13 7,422,355 (732,649) 77,908 (15)
Balance (in shares) at Mar. 31, 2026   7,000,000 120,103,455        
Balance at Mar. 31, 2026 6,238,928 $ 175,000 $ 12 6,676,618 (653,433) 40,641 90
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock, net of issuance costs (in shares)     4,272,317        
Issuance of common stock, net of issuance costs 312,872     312,872      
Repurchase of common shares (in shares)     (128)        
Repurchase of common shares (10)     (10)      
Issuance of restricted stock under the 2024 Omnibus Incentive Plan (in shares)     7,218        
Forfeiture of restricted stock (in shares)     (1,648)        
Forfeiture of restricted stock (4)     (4)      
Stock-based compensation 3,779     3,779      
Series A preferred dividends declared for the period (1,859) (1,859)          
Dividends and distributions declared for the period (97,624)       (97,346)   (278)
Amortization, changes in fair value, and settlement of interest rate swaps 9,240         9,213 27
Net income 54,809 $ 1,859     52,794   156
Balance (in shares) at Jun. 30, 2026   7,000,000 124,381,214        
Balance at Jun. 30, 2026 6,520,131 $ 175,000 $ 12 6,993,255 (697,985) 49,854 (5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock, net of issuance costs (in shares)     5,722,117        
Issuance of common stock, net of issuance costs 425,537   $ 1 425,536      
Repurchase of common shares (in shares)     (1,140)        
Repurchase of common shares (86)     (86)      
Issuance of restricted stock under the 2024 Omnibus Incentive Plan (in shares)     42        
Forfeiture of restricted stock (in shares)     (1,202)        
Forfeiture of restricted stock (14)     (14)      
Stock-based compensation 3,664     3,664      
Series A preferred dividends declared for the period (1,859) (1,859)          
Dividends and distributions declared for the period (101,436)       (101,157)   (279)
Amortization, changes in fair value, and settlement of interest rate swaps 28,132         28,054 78
Net income 68,543 $ 1,859     66,493   191
Balance (in shares) at Sep. 30, 2026   7,000,000 130,101,031        
Balance at Sep. 30, 2026 $ 6,942,612 $ 175,000 $ 13 $ 7,422,355 $ (732,649) $ 77,908 $ (15)